These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 7506295)
1. Antigenic and immunogenic differences in lipopolysaccharides of Escherichia coli J5 vaccine strains of different origins. Appelmelk BJ; Maaskant JJ; Verweij-van Vught AM; van der Meer NM; Thijs BG; MacLaren DM J Gen Microbiol; 1993 Nov; 139(11):2641-7. PubMed ID: 7506295 [TBL] [Abstract][Full Text] [Related]
2. Immunoprotective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia coli 0111:B4 lipopolysaccharide (LPS). Coughlin RT; Bogard WC J Immunol; 1987 Jul; 139(2):557-61. PubMed ID: 3298431 [TBL] [Abstract][Full Text] [Related]
3. Antigenic homology of endotoxin with a coliform mastitis vaccine strain, Escherichia coli O111:B4 (J5). Tyler JW; Spears H; Nelson R J Dairy Sci; 1992 Jul; 75(7):1821-5. PubMed ID: 1500577 [TBL] [Abstract][Full Text] [Related]
4. A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia. Bhattacharjee AK; Opal SM; Taylor R; Naso R; Semenuk M; Zollinger WD; Moran EE; Young L; Hammack C; Sadoff JC; Cross AS J Infect Dis; 1996 May; 173(5):1157-63. PubMed ID: 8627067 [TBL] [Abstract][Full Text] [Related]
5. Characterization of anti-core glycolipid monoclonal antibodies with chemically defined lipopolysaccharides. de Jongh-Leuvenink J; Schellekens J; Verhoef J Infect Immun; 1990 Feb; 58(2):421-6. PubMed ID: 2404871 [TBL] [Abstract][Full Text] [Related]
6. Development of an anti-core lipopolysaccharide vaccine for the prevention and treatment of sepsis. Cross AS; Opal S; Cook P; Drabick J; Bhattacharjee A Vaccine; 2004 Feb; 22(7):812-7. PubMed ID: 15040932 [TBL] [Abstract][Full Text] [Related]
7. Antibodies to lipopolysaccharides after immunization of humans with the rough mutant Escherichia coli J5. Baumgartner JD; Heumann D; Calandra T; Glauser MP J Infect Dis; 1991 Apr; 163(4):769-72. PubMed ID: 2010630 [TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide heterogeneity in Escherichia coli J5 variants: analysis by flow cytometry. Evans ME; Pollack M; Koles NL; Hardegen NJ; Panopoulos D J Infect Dis; 1992 Oct; 166(4):803-11. PubMed ID: 1527415 [TBL] [Abstract][Full Text] [Related]
9. Cross-reactivity of monoclonal antibodies to Escherichia coli J5 with heterologous gram-negative bacteria and extracted lipopolysaccharides. Aydintug MK; Inzana TJ; Letonja T; Davis WC; Corbeil LB J Infect Dis; 1989 Nov; 160(5):846-57. PubMed ID: 2681436 [TBL] [Abstract][Full Text] [Related]
10. Immunochemical specificity of human antibodies to lipopolysaccharide from the J5 rough mutant of Escherichia coli O111:B4. Schwartzer TA; Alcid DV; Numsuwan V; Gocke DJ J Infect Dis; 1989 Jan; 159(1):35-42. PubMed ID: 2462603 [TBL] [Abstract][Full Text] [Related]
11. Immunization of cows with novel core glycolipid vaccine induces anti-endotoxin antibodies in bovine colostrum. Cross AS; Karreman HJ; Zhang L; Rosenberg Z; Opal SM; Lees A Vaccine; 2014 Oct; 32(46):6107-14. PubMed ID: 25242628 [TBL] [Abstract][Full Text] [Related]
12. [Anti-endotoxin core glycolipid antibody: the preparation of immune serum of E. Coli J5]. Xu XN; Li ZJ; Li YP Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Jun; 16(6):358-60. PubMed ID: 15182450 [TBL] [Abstract][Full Text] [Related]
14. Production and characterisation of mouse monoclonal antibodies reacting with the lipopolysaccharide core region of gram-negative bacilli. Appelmelk BJ; Verweij-van Vught AM; Maaskant JJ; Schouten WF; De Jonge AJ; Thijs LG; Maclaren DM J Med Microbiol; 1988 Jun; 26(2):107-14. PubMed ID: 2455054 [TBL] [Abstract][Full Text] [Related]
15. Cross-reactivity of rabbit antibodies to lipopolysaccharides of Escherichia coli J5 and other gram-negative bacteria. Siber GR; Kania SA; Warren HS J Infect Dis; 1985 Nov; 152(5):954-64. PubMed ID: 2413146 [TBL] [Abstract][Full Text] [Related]
16. The disaccharide L-alpha-D-heptose1-->7-L-alpha-D-heptose1-->of the inner core domain of Salmonella lipopolysaccharide is accessible to antibody and is the epitope of a broadly reactive monoclonal antibody. Nnalue NA; Lind SM; Lindberg AA J Immunol; 1992 Oct; 149(8):2722-8. PubMed ID: 1383323 [TBL] [Abstract][Full Text] [Related]
17. Antigenic and immunogenic characteristics of subcellular fractions and whole cells of a rough E. coli 0111 (J5) mutant. Sakulramrung R; Domingue GJ Immunobiology; 1985 May; 169(4):372-88. PubMed ID: 2408995 [TBL] [Abstract][Full Text] [Related]
18. Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide. Marks MI; Ziegler EJ; Douglas H; Corbeil LB; Braude AI J Clin Invest; 1982 Apr; 69(4):742-9. PubMed ID: 7042755 [TBL] [Abstract][Full Text] [Related]